ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Urological Medications Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-39R7519
Home | Market Reports | Health| Men s Health
Global Urological Medications Market Insights Forecast to 2028
BUY CHAPTERS

Global Urological Medications Market Research Report 2025

Code: QYRE-Auto-39R7519
Report
July 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Viatris
Pfizer Inc
Merck
Astellas Pharma
Abbott
Advanz Pharma
GlaxoSmithKline PLC
Bayer HealthCare Pharmaceuticals
Novartis
Piramal Pharma Solutions
Endo International
Sanofi-aventis U.S. LLC
AbbVie
Mallinckrodt plc
Lilly

Urological Medications Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Urological Medications Market

Urological Medications Market

The global market for Urological Medications was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Urological Medications are drugs used in the treatment of urogenital conditions and diseases such as SUI,BPH,OAB and ED.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Urological Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urological Medications.
The Urological Medications market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Urological Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urological Medications companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Urological Medications Market Report

Report Metric Details
Report Name Urological Medications Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Viatris, Pfizer, Merck, Astellas Pharma, Abbott, ADVANZ PHARMA, GlaxoSmithKline, Bayer HealthCare Pharmaceuticals, Novartis, Piramal Pharma Solutions, Endo International, Sanofi-aventis U.S. LLC, AbbVie, Mallinckrodt, Lilly
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Urological Medications company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Urological Medications Market report?

Ans: The main players in the Urological Medications Market are Viatris, Pfizer, Merck, Astellas Pharma, Abbott, ADVANZ PHARMA, GlaxoSmithKline, Bayer HealthCare Pharmaceuticals, Novartis, Piramal Pharma Solutions, Endo International, Sanofi-aventis U.S. LLC, AbbVie, Mallinckrodt, Lilly

What are the Application segmentation covered in the Urological Medications Market report?

Ans: The Applications covered in the Urological Medications Market report are SUI, BPH, OAB, ED, Prostate Cancer, Others

What are the Type segmentation covered in the Urological Medications Market report?

Ans: The Types covered in the Urological Medications Market report are Alpha Blockers, 5-Alpha Inhibitors, Anticholinergics, Others

Recommended Reports

Urological Drug Markets

Urological Device & Therapy

Broader Genitourinary Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urological Medications Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Alpha Blockers
1.2.3 5-Alpha Inhibitors
1.2.4 Anticholinergics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Urological Medications Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 SUI
1.3.3 BPH
1.3.4 OAB
1.3.5 ED
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urological Medications Market Perspective (2020-2031)
2.2 Global Urological Medications Growth Trends by Region
2.2.1 Global Urological Medications Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Urological Medications Historic Market Size by Region (2020-2025)
2.2.3 Urological Medications Forecasted Market Size by Region (2026-2031)
2.3 Urological Medications Market Dynamics
2.3.1 Urological Medications Industry Trends
2.3.2 Urological Medications Market Drivers
2.3.3 Urological Medications Market Challenges
2.3.4 Urological Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urological Medications Players by Revenue
3.1.1 Global Top Urological Medications Players by Revenue (2020-2025)
3.1.2 Global Urological Medications Revenue Market Share by Players (2020-2025)
3.2 Global Urological Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Urological Medications Revenue
3.4 Global Urological Medications Market Concentration Ratio
3.4.1 Global Urological Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urological Medications Revenue in 2024
3.5 Global Key Players of Urological Medications Head office and Area Served
3.6 Global Key Players of Urological Medications, Product and Application
3.7 Global Key Players of Urological Medications, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Urological Medications Breakdown Data by Type
4.1 Global Urological Medications Historic Market Size by Type (2020-2025)
4.2 Global Urological Medications Forecasted Market Size by Type (2026-2031)
5 Urological Medications Breakdown Data by Application
5.1 Global Urological Medications Historic Market Size by Application (2020-2025)
5.2 Global Urological Medications Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Urological Medications Market Size (2020-2031)
6.2 North America Urological Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Urological Medications Market Size by Country (2020-2025)
6.4 North America Urological Medications Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Urological Medications Market Size (2020-2031)
7.2 Europe Urological Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Urological Medications Market Size by Country (2020-2025)
7.4 Europe Urological Medications Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Urological Medications Market Size (2020-2031)
8.2 Asia-Pacific Urological Medications Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Urological Medications Market Size by Region (2020-2025)
8.4 Asia-Pacific Urological Medications Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Urological Medications Market Size (2020-2031)
9.2 Latin America Urological Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Urological Medications Market Size by Country (2020-2025)
9.4 Latin America Urological Medications Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urological Medications Market Size (2020-2031)
10.2 Middle East & Africa Urological Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Urological Medications Market Size by Country (2020-2025)
10.4 Middle East & Africa Urological Medications Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Viatris
11.1.1 Viatris Company Details
11.1.2 Viatris Business Overview
11.1.3 Viatris Urological Medications Introduction
11.1.4 Viatris Revenue in Urological Medications Business (2020-2025)
11.1.5 Viatris Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Urological Medications Introduction
11.2.4 Pfizer Revenue in Urological Medications Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Urological Medications Introduction
11.3.4 Merck Revenue in Urological Medications Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Urological Medications Introduction
11.4.4 Astellas Pharma Revenue in Urological Medications Business (2020-2025)
11.4.5 Astellas Pharma Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Urological Medications Introduction
11.5.4 Abbott Revenue in Urological Medications Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 ADVANZ PHARMA
11.6.1 ADVANZ PHARMA Company Details
11.6.2 ADVANZ PHARMA Business Overview
11.6.3 ADVANZ PHARMA Urological Medications Introduction
11.6.4 ADVANZ PHARMA Revenue in Urological Medications Business (2020-2025)
11.6.5 ADVANZ PHARMA Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Urological Medications Introduction
11.7.4 GlaxoSmithKline Revenue in Urological Medications Business (2020-2025)
11.7.5 GlaxoSmithKline Recent Development
11.8 Bayer HealthCare Pharmaceuticals
11.8.1 Bayer HealthCare Pharmaceuticals Company Details
11.8.2 Bayer HealthCare Pharmaceuticals Business Overview
11.8.3 Bayer HealthCare Pharmaceuticals Urological Medications Introduction
11.8.4 Bayer HealthCare Pharmaceuticals Revenue in Urological Medications Business (2020-2025)
11.8.5 Bayer HealthCare Pharmaceuticals Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Urological Medications Introduction
11.9.4 Novartis Revenue in Urological Medications Business (2020-2025)
11.9.5 Novartis Recent Development
11.10 Piramal Pharma Solutions
11.10.1 Piramal Pharma Solutions Company Details
11.10.2 Piramal Pharma Solutions Business Overview
11.10.3 Piramal Pharma Solutions Urological Medications Introduction
11.10.4 Piramal Pharma Solutions Revenue in Urological Medications Business (2020-2025)
11.10.5 Piramal Pharma Solutions Recent Development
11.11 Endo International
11.11.1 Endo International Company Details
11.11.2 Endo International Business Overview
11.11.3 Endo International Urological Medications Introduction
11.11.4 Endo International Revenue in Urological Medications Business (2020-2025)
11.11.5 Endo International Recent Development
11.12 Sanofi-aventis U.S. LLC
11.12.1 Sanofi-aventis U.S. LLC Company Details
11.12.2 Sanofi-aventis U.S. LLC Business Overview
11.12.3 Sanofi-aventis U.S. LLC Urological Medications Introduction
11.12.4 Sanofi-aventis U.S. LLC Revenue in Urological Medications Business (2020-2025)
11.12.5 Sanofi-aventis U.S. LLC Recent Development
11.13 AbbVie
11.13.1 AbbVie Company Details
11.13.2 AbbVie Business Overview
11.13.3 AbbVie Urological Medications Introduction
11.13.4 AbbVie Revenue in Urological Medications Business (2020-2025)
11.13.5 AbbVie Recent Development
11.14 Mallinckrodt
11.14.1 Mallinckrodt Company Details
11.14.2 Mallinckrodt Business Overview
11.14.3 Mallinckrodt Urological Medications Introduction
11.14.4 Mallinckrodt Revenue in Urological Medications Business (2020-2025)
11.14.5 Mallinckrodt Recent Development
11.15 Lilly
11.15.1 Lilly Company Details
11.15.2 Lilly Business Overview
11.15.3 Lilly Urological Medications Introduction
11.15.4 Lilly Revenue in Urological Medications Business (2020-2025)
11.15.5 Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Viatris
Pfizer Inc
Merck
Astellas Pharma
Abbott
Advanz Pharma
GlaxoSmithKline PLC
Bayer HealthCare Pharmaceuticals
Novartis
Piramal Pharma Solutions
Endo International
Sanofi-aventis U.S. LLC
AbbVie
Mallinckrodt plc
Lilly
List of Tables
 Table 1. Global Urological Medications Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Alpha Blockers
 Table 3. Key Players of 5-Alpha Inhibitors
 Table 4. Key Players of Anticholinergics
 Table 5. Key Players of Others
 Table 6. Global Urological Medications Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Urological Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Urological Medications Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Urological Medications Market Share by Region (2020-2025)
 Table 10. Global Urological Medications Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Urological Medications Market Share by Region (2026-2031)
 Table 12. Urological Medications Market Trends
 Table 13. Urological Medications Market Drivers
 Table 14. Urological Medications Market Challenges
 Table 15. Urological Medications Market Restraints
 Table 16. Global Urological Medications Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Urological Medications Market Share by Players (2020-2025)
 Table 18. Global Top Urological Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urological Medications as of 2024)
 Table 19. Ranking of Global Top Urological Medications Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Urological Medications Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Urological Medications, Headquarters and Area Served
 Table 22. Global Key Players of Urological Medications, Product and Application
 Table 23. Global Key Players of Urological Medications, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Urological Medications Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Urological Medications Revenue Market Share by Type (2020-2025)
 Table 27. Global Urological Medications Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Urological Medications Revenue Market Share by Type (2026-2031)
 Table 29. Global Urological Medications Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Urological Medications Revenue Market Share by Application (2020-2025)
 Table 31. Global Urological Medications Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Urological Medications Revenue Market Share by Application (2026-2031)
 Table 33. North America Urological Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Urological Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Urological Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Urological Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Urological Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Urological Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Urological Medications Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Urological Medications Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Urological Medications Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Urological Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Urological Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Urological Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Urological Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Urological Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Urological Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Viatris Company Details
 Table 49. Viatris Business Overview
 Table 50. Viatris Urological Medications Product
 Table 51. Viatris Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 52. Viatris Recent Development
 Table 53. Pfizer Company Details
 Table 54. Pfizer Business Overview
 Table 55. Pfizer Urological Medications Product
 Table 56. Pfizer Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 57. Pfizer Recent Development
 Table 58. Merck Company Details
 Table 59. Merck Business Overview
 Table 60. Merck Urological Medications Product
 Table 61. Merck Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 62. Merck Recent Development
 Table 63. Astellas Pharma Company Details
 Table 64. Astellas Pharma Business Overview
 Table 65. Astellas Pharma Urological Medications Product
 Table 66. Astellas Pharma Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 67. Astellas Pharma Recent Development
 Table 68. Abbott Company Details
 Table 69. Abbott Business Overview
 Table 70. Abbott Urological Medications Product
 Table 71. Abbott Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 72. Abbott Recent Development
 Table 73. ADVANZ PHARMA Company Details
 Table 74. ADVANZ PHARMA Business Overview
 Table 75. ADVANZ PHARMA Urological Medications Product
 Table 76. ADVANZ PHARMA Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 77. ADVANZ PHARMA Recent Development
 Table 78. GlaxoSmithKline Company Details
 Table 79. GlaxoSmithKline Business Overview
 Table 80. GlaxoSmithKline Urological Medications Product
 Table 81. GlaxoSmithKline Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 82. GlaxoSmithKline Recent Development
 Table 83. Bayer HealthCare Pharmaceuticals Company Details
 Table 84. Bayer HealthCare Pharmaceuticals Business Overview
 Table 85. Bayer HealthCare Pharmaceuticals Urological Medications Product
 Table 86. Bayer HealthCare Pharmaceuticals Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 87. Bayer HealthCare Pharmaceuticals Recent Development
 Table 88. Novartis Company Details
 Table 89. Novartis Business Overview
 Table 90. Novartis Urological Medications Product
 Table 91. Novartis Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 92. Novartis Recent Development
 Table 93. Piramal Pharma Solutions Company Details
 Table 94. Piramal Pharma Solutions Business Overview
 Table 95. Piramal Pharma Solutions Urological Medications Product
 Table 96. Piramal Pharma Solutions Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 97. Piramal Pharma Solutions Recent Development
 Table 98. Endo International Company Details
 Table 99. Endo International Business Overview
 Table 100. Endo International Urological Medications Product
 Table 101. Endo International Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 102. Endo International Recent Development
 Table 103. Sanofi-aventis U.S. LLC Company Details
 Table 104. Sanofi-aventis U.S. LLC Business Overview
 Table 105. Sanofi-aventis U.S. LLC Urological Medications Product
 Table 106. Sanofi-aventis U.S. LLC Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 107. Sanofi-aventis U.S. LLC Recent Development
 Table 108. AbbVie Company Details
 Table 109. AbbVie Business Overview
 Table 110. AbbVie Urological Medications Product
 Table 111. AbbVie Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 112. AbbVie Recent Development
 Table 113. Mallinckrodt Company Details
 Table 114. Mallinckrodt Business Overview
 Table 115. Mallinckrodt Urological Medications Product
 Table 116. Mallinckrodt Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 117. Mallinckrodt Recent Development
 Table 118. Lilly Company Details
 Table 119. Lilly Business Overview
 Table 120. Lilly Urological Medications Product
 Table 121. Lilly Revenue in Urological Medications Business (2020-2025) & (US$ Million)
 Table 122. Lilly Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Urological Medications Picture
 Figure 2. Global Urological Medications Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Urological Medications Market Share by Type: 2024 VS 2031
 Figure 4. Alpha Blockers Features
 Figure 5. 5-Alpha Inhibitors Features
 Figure 6. Anticholinergics Features
 Figure 7. Others Features
 Figure 8. Global Urological Medications Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Urological Medications Market Share by Application: 2024 VS 2031
 Figure 10. SUI Case Studies
 Figure 11. BPH Case Studies
 Figure 12. OAB Case Studies
 Figure 13. ED Case Studies
 Figure 14. Prostate Cancer Case Studies
 Figure 15. Others Case Studies
 Figure 16. Urological Medications Report Years Considered
 Figure 17. Global Urological Medications Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Urological Medications Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Urological Medications Market Share by Region: 2024 VS 2031
 Figure 20. Global Urological Medications Market Share by Players in 2024
 Figure 21. Global Top Urological Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urological Medications as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Urological Medications Revenue in 2024
 Figure 23. North America Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Urological Medications Market Share by Country (2020-2031)
 Figure 25. United States Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Urological Medications Market Share by Country (2020-2031)
 Figure 29. Germany Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Urological Medications Market Share by Region (2020-2031)
 Figure 37. China Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Urological Medications Market Share by Country (2020-2031)
 Figure 45. Mexico Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Urological Medications Market Share by Country (2020-2031)
 Figure 49. Turkey Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Urological Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Viatris Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 53. Pfizer Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 54. Merck Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 55. Astellas Pharma Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 56. Abbott Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 57. ADVANZ PHARMA Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 58. GlaxoSmithKline Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 59. Bayer HealthCare Pharmaceuticals Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 60. Novartis Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 61. Piramal Pharma Solutions Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 62. Endo International Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 63. Sanofi-aventis U.S. LLC Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 64. AbbVie Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 65. Mallinckrodt Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 66. Lilly Revenue Growth Rate in Urological Medications Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Urology Drugs Market Insights Forecast to 2030
Urological Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urological Cancer Drugs Market Research Report 2024
Urology Medical Laser Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urology Surgery Laser Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Genitourinary Cancers Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urological Cancer Therapeutics Drugs Market Research Report 2024
Global Urinary Products Market Research Report 2025
Urinary Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urology Care Device and Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urinary Tract Infection UTI Medications Market Research Report 2025
Renal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urinary System Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urinary Incontinence Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urinary Tract Cancer Treatment Market Research Report 2024
Bladder Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urinary Tract Health Supplements Market Research Report 2025
Urological Forceps Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cystourethroscope Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Testicular Cancer Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26B6701
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Prostate Cancer Biomarker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12M6232
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Benign Prostatic Hyperplasia Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39G5907
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Prostate Cancer Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7B2445
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions